Back to search

Institutes outside Greece

The role of SOX2 in regulation of pluripotency and early cell fate decisions in embryos and embryonic stem cells

Abstract

dc:description

The transcription factor Sox2 (SRY-related HMG box gene 2) plays a pivotal role in maintaining self-renewal and pluripotency in embryonic stem (ES) cells derived from the inner cell mass (ICM) of the embryo. Previously it was shown that Sox2-/mouse embryos die soon after implantation, however, maternal Sox2 transcripts may mask an earlier phenotype. This study has shown that siRNA knock-down of Sox2 at the 2-cell stage of the preimplantation mouse embryo results in embryo arrest at the morula stage, increased cellular apoptosis and loss of ability to generate the first differentiated tissue in the embryo, the trophectoderm (TE). Loss of TE probably results from lack of Fgf4-Fgfr2 signaling or because Sox2 directly activates Cdx2. This novel result suggests a much earlier role for Sox2 than previously reported. While expression of stem-related genes such as Oct4 and Nanog was retained in the RNAi-induced absence of Sox2, molecules required for commitment to trophectoderm (Cdx2, Eomes, Fgfr2 and Fgf4) or establishment of the trophectoderm epithelium (Occludin) were lost and blastocyst formation was prevented (only 18.7-21% embryos formed blastocysts). Knock-down of Sox2 in mouse ES cells using shRNA plasmid vectors resulted in alterations in the expression of a number of genes associated with pluripotency, commitment to trophectoderm, mesendoderm, neuroectoderm and cell-cycle regulation. The most striking impact of knocking down Sox2 in mES cells was the significant upregulation of the trophectoderm markers Cdx2 and Eomes, and of the mesendoderm markers Mixl1, Goosecoid and Brachyury. In a culture environment designed to promote neurogenesis, Sox2 shRNA cells acquired a more glial (astrocytic) phenotype. Absence of Sox2 resulted in a severe compromise of ES cell growth rate, loss of self renewal and cell-cycle arrest, in the absence of increased apoptosis. SOX2 shRNA knock-down in hES cells resulted in loss of pluripotency markers, and upregulation of trophectoderm and mesendoderm markers. The above findings suggest that while Sox2 in the early mouse embryo induces TE formation and is essential for the developmental transition from the morula to the blastocyst stage, in mES and hES cells it acts to maintain selfrenewal and inhibit trophectoderm and mesendoderm differentiation.

Degree

thesis:*
Grantor dc:publisher
Institutes outside Greece
Year dc:date
2009

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Keramari, Maria
  • Κεραμάρη, Μαρία

Subjects

dc:subject × 29

Rights

Language dc:language
eng

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/55132

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Keramari, Maria; Κεραμάρη, Μαρία. The role of SOX2 in regulation of pluripotency and early cell fate decisions in embryos and embryonic stem cells. Institutes outside Greece, 2009. http://hdl.handle.net/10442/hedi/55132